Please use this identifier to cite or link to this item: http://elar.urfu.ru/handle/10995/131204
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCharushin, V. N.en
dc.contributor.authorRusinov, V. L.en
dc.contributor.authorVaraksin, M. V.en
dc.contributor.authorChupakhin, O. N.en
dc.contributor.authorKovtun, O. P.en
dc.contributor.authorSpasov, A. A.en
dc.date.accessioned2024-04-08T11:05:41Z-
dc.date.available2024-04-08T11:05:41Z-
dc.date.issued2022-
dc.identifier.citationCharushin, VN, Rusinov, VL, Varaksin, MV, Chupakhin, ON, Kovtun, OP & Spasov, AA 2022, 'Development of Drugs with Direct Antiviral Action Based on Azaheterocyclic Systems', Herald of the Russian Academy of Sciences, Том. 92, № 4, стр. 505-510. https://doi.org/10.1134/S1019331622040104harvard_pure
dc.identifier.citationCharushin, V. N., Rusinov, V. L., Varaksin, M. V., Chupakhin, O. N., Kovtun, O. P., & Spasov, A. A. (2022). Development of Drugs with Direct Antiviral Action Based on Azaheterocyclic Systems. Herald of the Russian Academy of Sciences, 92(4), 505-510. https://doi.org/10.1134/S1019331622040104apa_pure
dc.identifier.issn1019-3316-
dc.identifier.otherFinal2
dc.identifier.otherAll Open Access; Bronze Open Access; Green Open Access3
dc.identifier.otherhttps://link.springer.com/content/pdf/10.1134/S1019331622040104.pdf1
dc.identifier.otherhttps://link.springer.com/content/pdf/10.1134/S1019331622040104.pdfpdf
dc.identifier.urihttp://elar.urfu.ru/handle/10995/131204-
dc.description.abstractAbstract: This article discusses the results of studies carried out in recent years by a team of scientists from the Postovskii Institute of Organic Synthesis, Ural Branch, Russian Academy of Sciences, in cooperation with the First President of Russia Boris Yeltsin Ural Federal University, Ural State Medical University, Volgograd State Medical University, and other scientific and production organizations of the country to create triazavirin (riamilovir) and other direct etiotropic antiviral drugs based on azaheterocyclic derivatives. © 2022, Pleiades Publishing, Ltd.en
dc.description.sponsorshipNational Natural Science Foundation of China, NSFC, (20-53-55003)en
dc.description.sponsorshipRussian Foundation for Basic Research, РФФИen
dc.description.sponsorshipThis work was supported by the Russian Foundation for Basic Research and the National Natural Science Foundation of China within research project no. 20-53-55003.en
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.publisherPleiades journalsen
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.sourceHerald of the Russian Academy of Sciences2
dc.sourceHerald of the Russian Academy of Sciencesen
dc.subjectAZOLOAZINESen
dc.subjectFAVIPIRAVIRen
dc.subjectMAIN PROTEASEen
dc.subjectMOLNUPIRAVIRen
dc.subjectPYRAZINESen
dc.subjectPYRIMIDINESen
dc.subjectREMDESIVIRen
dc.subjectRNA POLYMERASEen
dc.subjectTRIAZAVIRIN (RIAMILOVIR)en
dc.subjectTRIAZINESen
dc.titleDevelopment of Drugs with Direct Antiviral Action Based on Azaheterocyclic Systemsen
dc.typeArticleen
dc.typeinfo:eu-repo/semantics/articleen
dc.typeinfo:eu-repo/semantics/publishedVersionen
dc.identifier.doi10.1134/S1019331622040104-
dc.identifier.scopus85138049902-
local.contributor.employeeCharushin V.N., Postovskii Institute of Organic Synthesis (IOS), Ural Branch, Russian Academy of Sciences, Yekaterinburg, Russian Federation, First President of Russia Boris Yeltsin Ural Federal University (UrFU), Yekaterinburg, Russian Federationen
local.contributor.employeeRusinov V.L., Postovskii Institute of Organic Synthesis (IOS), Ural Branch, Russian Academy of Sciences, Yekaterinburg, Russian Federation, First President of Russia Boris Yeltsin Ural Federal University (UrFU), Yekaterinburg, Russian Federationen
local.contributor.employeeVaraksin M.V., Postovskii Institute of Organic Synthesis (IOS), Ural Branch, Russian Academy of Sciences, Yekaterinburg, Russian Federation, First President of Russia Boris Yeltsin Ural Federal University (UrFU), Yekaterinburg, Russian Federationen
local.contributor.employeeChupakhin O.N., Postovskii Institute of Organic Synthesis (IOS), Ural Branch, Russian Academy of Sciences, Yekaterinburg, Russian Federation, First President of Russia Boris Yeltsin Ural Federal University (UrFU), Yekaterinburg, Russian Federationen
local.contributor.employeeKovtun O.P., Ural State Medical University (UrSMU), Yekaterinburg, Russian Federationen
local.contributor.employeeSpasov A.A., Volgograd State Medical University (VSMU), Volgograd, Russian Federationen
local.description.firstpage505-
local.description.lastpage510-
local.issue4-
local.volume92-
local.contributor.departmentPostovskii Institute of Organic Synthesis (IOS), Ural Branch, Russian Academy of Sciences, Yekaterinburg, Russian Federationen
local.contributor.departmentFirst President of Russia Boris Yeltsin Ural Federal University (UrFU), Yekaterinburg, Russian Federationen
local.contributor.departmentUral State Medical University (UrSMU), Yekaterinburg, Russian Federationen
local.contributor.departmentVolgograd State Medical University (VSMU), Volgograd, Russian Federationen
local.identifier.pure30982440-
local.identifier.pure4394e055-c189-4941-a8cd-0acdb30345e4uuid
local.identifier.eid2-s2.0-85138049902-
Appears in Collections:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Files in This Item:
File Description SizeFormat 
2-s2.0-85138049902.pdf687,89 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.